AKT3 and neoplasm: Interestingly, this connects to a recently published work on Akt inhibitor resistance in castration-resistant prostate cancer (CRPC), where the authors also observed specific upregulation of Akt3, but not Akt1 or Akt2, in MK2206-resistance tumor cells [50].